Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma
0.400 PosttranslationalModification LHGDN Our results indicate that Por tumorigenesis strongly correlates with MSI and methylation of the p16 and hMLH1 promoter region. 18161865

2008

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma
0.400 AlteredExpression LHGDN Our data demonstrate that nuclear p16 expression is absent in normal gallbladder epithelium and is a frequent event in high-grade dysplasia of the gallbladder and gallbladder adenocarcinoma. 18486890

2008

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma
0.400 AlteredExpression LHGDN Thus, immunostaining for p16INK4a appears to be a useful diagnostic tool for cervical adenocarcinoma. 18202755

2008

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma
0.400 GeneticVariation LHGDN Simultaneous deregulation of p16 and cyclin D1 genes in pancreatic ductal adenocarcinoma: a combined immunohistochemistry and image analysis study based on tissue microarrays. 17600882

2007

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma
0.400 GeneticVariation LHGDN We identified thirteen loci showing significant differential DNA methylation levels between tumor and non-tumor lung; eight of these show highly significant hypermethylation in adenocarcinoma: CDH13, CDKN2A EX2, CDX2, HOXA1, OPCML, RASSF1, SFPR1, and TWIST1 (p-value < 0.0001). 17967182

2007

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma
0.400 AlteredExpression LHGDN The expression of p16(INK4A) protein is significantly higher in endocervical adenocarcinoma than in endometrial adenocarcinoma. 18346352

2007

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma
0.400 PosttranslationalModification LHGDN In comparison with adenocarcinomas of the stomach, SB-AC revealed a significantly higher rate of hypermethylation of HPP1 (86% versus 54%, p = 0.0003), p16(INK4A) (32% versus 10%, p = 0.0006), and a significantly lower rate of hypermethylation of APC (48% versus 84%, p = 0.0001). 16619216

2006

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma
0.400 GeneticVariation LHGDN Usefulness of p16 and K-ras mutation in pancreatic adenocarcinoma and chronic pancreatitis differential diagnosis. 15608367

2004

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma
0.400 GeneticVariation LHGDN Orthotopic transplantation models of pancreatic adenocarcinoma derived from cell lines and primary tumors and displaying varying metastatic activity. 15367885

2004

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma
0.400 Biomarker LHGDN Most primary endocervical adenocarcinomas were characterized by strong, diffuse positivity of 100% of cells with p16. 12819388

2003

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma
0.400 PosttranslationalModification LHGDN Of 114 gastric adenocarcinomas analyzed by immunohistochemistry, 34 cases (30%) were negative for p16 protein. 12514789

2002